Is there a role for voice therapy in the treatment of laryngopharyngeal reflux? A pilot study
Copyright © 2024 Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy..
Objective: The aim of this study was to compare the efficacy of voice therapy combined with standard anti-reflux therapy in reducing symptoms and signs of laryngopharyngeal reflux (LPR).
Methods: A randomised clinical trial was conducted. Fifty-two patients with LPR diagnosed by 24 h multichannel intraluminal impedance-pH monitoring were randomly allocated in two groups: medical treatment (MT) and medical plus voice therapy (VT). Clinical symptoms and laryngeal signs were assessed at baseline and after 3 months of treatment with the Reflux Symptom Index (RSI), Reflux Finding Score (RFS), Voice Handicap Index (VHI) and GRBAS scales.
Results: Groups had similar scores at baseline. At 3-month follow-up, a significant decrease in RSI and RFS total scores were found in both groups although it appeared to be more robust in the VT group. G and R scores of the GRBAS scale significantly improved after treatment in both groups, with better results in the VT group. The VHI total score at 3 months improved more in the VT group (VHI delta 9.54) than in the MT group (VHI delta 5.38) (p < 0.001).
Conclusions: The addition of voice therapy to medications and diet appears to be more effective in improving treatment outcomes in subjects with LPR. Voice therapy warrants consideration in addition to medication and diet when treating patients with LPR.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
---|---|
Enthalten in: |
Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale - 44(2024), 1 vom: 28. Feb., Seite 27-35 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Barillari, Maria Rosaria [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Completed 01.03.2024 Date Revised 07.03.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.14639/0392-100X-N2742 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369106393 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369106393 | ||
003 | DE-627 | ||
005 | 20240307232444.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240301s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.14639/0392-100X-N2742 |2 doi | |
028 | 5 | 2 | |a pubmed24n1319.xml |
035 | |a (DE-627)NLM369106393 | ||
035 | |a (NLM)38420719 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Barillari, Maria Rosaria |e verfasserin |4 aut | |
245 | 1 | 0 | |a Is there a role for voice therapy in the treatment of laryngopharyngeal reflux? A pilot study |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.03.2024 | ||
500 | |a Date Revised 07.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 Società Italiana di Otorinolaringoiatria e Chirurgia Cervico-Facciale, Rome, Italy. | ||
520 | |a Objective: The aim of this study was to compare the efficacy of voice therapy combined with standard anti-reflux therapy in reducing symptoms and signs of laryngopharyngeal reflux (LPR) | ||
520 | |a Methods: A randomised clinical trial was conducted. Fifty-two patients with LPR diagnosed by 24 h multichannel intraluminal impedance-pH monitoring were randomly allocated in two groups: medical treatment (MT) and medical plus voice therapy (VT). Clinical symptoms and laryngeal signs were assessed at baseline and after 3 months of treatment with the Reflux Symptom Index (RSI), Reflux Finding Score (RFS), Voice Handicap Index (VHI) and GRBAS scales | ||
520 | |a Results: Groups had similar scores at baseline. At 3-month follow-up, a significant decrease in RSI and RFS total scores were found in both groups although it appeared to be more robust in the VT group. G and R scores of the GRBAS scale significantly improved after treatment in both groups, with better results in the VT group. The VHI total score at 3 months improved more in the VT group (VHI delta 9.54) than in the MT group (VHI delta 5.38) (p < 0.001) | ||
520 | |a Conclusions: The addition of voice therapy to medications and diet appears to be more effective in improving treatment outcomes in subjects with LPR. Voice therapy warrants consideration in addition to medication and diet when treating patients with LPR | ||
650 | 4 | |a Randomized Controlled Trial | |
650 | 4 | |a Journal Article | |
650 | 4 | |a laryngopharyngeal reflux | |
650 | 4 | |a multichannel intraluminal impedance-pH monitoring | |
650 | 4 | |a treatment | |
650 | 4 | |a voice therapy | |
650 | 7 | |a Proton Pump Inhibitors |2 NLM | |
700 | 1 | |a Nacci, Andrea |e verfasserin |4 aut | |
700 | 1 | |a Bastiani, Luca |e verfasserin |4 aut | |
700 | 1 | |a Mirra, Giuseppina |e verfasserin |4 aut | |
700 | 1 | |a Costa, Giuseppe |e verfasserin |4 aut | |
700 | 1 | |a Maniaci, Antonino |e verfasserin |4 aut | |
700 | 1 | |a Docimo, Ludovico |e verfasserin |4 aut | |
700 | 1 | |a Tolone, Salvatore |e verfasserin |4 aut | |
700 | 1 | |a Giumello, Federica |e verfasserin |4 aut | |
700 | 1 | |a Minichilli, Fabrizio |e verfasserin |4 aut | |
700 | 1 | |a Chiesa Estomba, Carlos M |e verfasserin |4 aut | |
700 | 1 | |a Lechien, Jerome R |e verfasserin |4 aut | |
700 | 1 | |a Carroll, Thomas L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale |d 1985 |g 44(2024), 1 vom: 28. Feb., Seite 27-35 |w (DE-627)NLM01279046X |x 1827-675X |7 nnns |
773 | 1 | 8 | |g volume:44 |g year:2024 |g number:1 |g day:28 |g month:02 |g pages:27-35 |
856 | 4 | 0 | |u http://dx.doi.org/10.14639/0392-100X-N2742 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 44 |j 2024 |e 1 |b 28 |c 02 |h 27-35 |